Lluís Alcover, Autor en Faus & Moliner Abogados

Incoterms® 2020

An updated version of the Incoterms of the International Chamber of Commerce (ICC) enters into force

Lluís Alcover, Juan Martínez

3 Feb 2020

Capsulas Nº 207

VALTERMED

Lluís Alcover

27 Jan 2020

CUADERNOS DE DERECHO FARMACÉUTICO, NUMBER. 71, OCTOBER-DECEMBER 2019

Balancing transparency and confidentiality

Opinions of the Advocate General, Mr. Gerard Hogan, of 11 September 2019, on Cases C-175/18 and C-178/18; and resolution of the CTBG of 26 September 2019

Lluís Alcover

15 Oct 2019

Capsulas Nº 204

The Pharma Legal Handbook: Spain

Faus & Moliner has participated in the publication of the first edition of the Spanish chapter of the The Pharma Legal Handbook guide, edited by PharmaBoardroom

Lluís Alcover, Verónica Carías, Laura Marquès, Eduard Rodellar and Juan Martínez

1 Aug 2019

The Pharma Legal Handbook

The direct action of the operating carrier against the companies preceding it in the subcontracting chain

Judgment of the Supreme Court of 6 May 2019

Lluís Alcover

1 Jul 2019

Capsulas Nº 202

When deciding about medicines, the impartiality of the institutions of the EU is out of discussion

Judgement of the Court of Justice of the European Union (CJEU) of 27 March 2019, Dr. August Wolf v the European Commission, Case C-680/16 P

Lluís Alcover

27 May 2019

Capsulas Nº 201

Promotion of prescription glasses (considered as medical devices) and discriminatory advertising

Decisions of the Jury of Advertising of Autocontrol on prescription glasses (January 2019) and on discriminatory advertising (December 2018)

Lluís Alcover

26 Feb 2019

Capsulas Nº 199

New requirements regarding non-financial information to be included in the annual accounts

Law 11/2018, amending the Code of Commerce, the Law on Companies and the Law on the Auditing of Accounts

Lluís Alcover, Jordi Faus

1 Feb 2019

Capsulas Nº198

Clarification of the authorization process for the cultivation of cannabis for research, medical or scientific purposes

Information notes from the Division of Inspection and Control of Medicines of the Spanish Agency of Medicines and Medical Devices (AEMPS) published in the AEMPS’ website

Lluís Alcover

1 Feb 2019

Capsulas Nº 198

Is it possible for a substance evaluated under the medical devices’ rules to benefit from a SPC?

Judgement of the Court of Justice of the European Union (CJEU), of 25 October 2018, in the Case C-527/17 Boston Scientific v Deutsches Patent

Lluís Alcover

30 Nov 2018

Incoterms® 2020

An updated version of the Incoterms of the International Chamber of Commerce (ICC) enters into force

Capsulas Nº 207

VALTERMED

CUADERNOS DE DERECHO FARMACÉUTICO, NUMBER. 71, OCTOBER-DECEMBER 2019

Balancing transparency and confidentiality

Opinions of the Advocate General, Mr. Gerard Hogan, of 11 September 2019, on Cases C-175/18 and C-178/18; and resolution of the CTBG of 26 September 2019

Capsulas Nº 204

The Pharma Legal Handbook: Spain

Faus & Moliner has participated in the publication of the first edition of the Spanish chapter of the The Pharma Legal Handbook guide, edited by PharmaBoardroom

The Pharma Legal Handbook

The direct action of the operating carrier against the companies preceding it in the subcontracting chain

Judgment of the Supreme Court of 6 May 2019

Capsulas Nº 202

When deciding about medicines, the impartiality of the institutions of the EU is out of discussion

Judgement of the Court of Justice of the European Union (CJEU) of 27 March 2019, Dr. August Wolf v the European Commission, Case C-680/16 P

Capsulas Nº 201

Promotion of prescription glasses (considered as medical devices) and discriminatory advertising

Decisions of the Jury of Advertising of Autocontrol on prescription glasses (January 2019) and on discriminatory advertising (December 2018)

Capsulas Nº 199

New requirements regarding non-financial information to be included in the annual accounts

Law 11/2018, amending the Code of Commerce, the Law on Companies and the Law on the Auditing of Accounts

Capsulas Nº198

Clarification of the authorization process for the cultivation of cannabis for research, medical or scientific purposes

Information notes from the Division of Inspection and Control of Medicines of the Spanish Agency of Medicines and Medical Devices (AEMPS) published in the AEMPS’ website

Capsulas Nº 198

Is it possible for a substance evaluated under the medical devices’ rules to benefit from a SPC?

Judgement of the Court of Justice of the European Union (CJEU), of 25 October 2018, in the Case C-527/17 Boston Scientific v Deutsches Patent

Capsulas Nº196

Uso de cookies